WebHAYA Therapeutics raised $5,000,000 / Seed from 4See Ventures and 6 other investors . ... HAYA Therapeutics SA raised $18,000,000 / Seed from 4See Ventures and 5 other investors . Discover more funding rounds . View All . Details. Edit Details Section. Founded Date 2024; Operating Status Active; Investor Type Venture Capital Lists Featuring ... WebHAYA Therapeutics SA has 6 investors including Apollo Health Ventures and Viva BioInnovator. How much funding has HAYA Therapeutics SA raised to date? HAYA Therapeutics SA has raised $18M. When was the last funding round for HAYA Therapeutics SA? HAYA Therapeutics SA closed its last funding round on May 5, …

HAYA Therapeutics SA – Swiss Biotech

WebFeb 3, 2024 · Could long non-coding RNAs be the key to developing organ-specific antifibrotic drugs that only mediate their effects in disease-related contexts? That’s the intriguing hypothesis that Haya Therapeutics SA has set out to explore, and its lead program, in heart failure caused by non-obstructive hypertrophic cardiomyopathy, is now … WebOct 2, 2024 · 16.12.2024 The 18 most promising biotech startups, according to investors (TOP 100) 14.10.2024 International and seasoned board members for Switzerland … new launch of maruti suzuki

HAYA Therapeutics SA - 天眼查

WebHAYA Therapeutics SA Route De La Corniche 6 SuperLab Suisse – Batiment Serine 1066 Epalinges, Lausanne Vaud, Switzerland [email protected] San Diego HAYA … WebMay 3, 2024 · HAYA Therapeutics is a precision therapeutics company that discovers and develops innovative tissue- and cell-selective genomic medicines for fibrotic diseases and other serious health conditions ... WebSep 15, 2024 · HAYA Therapeutics, SA, a company developing RNA-guided programmable precision medicines focused on long non-coding RNAs (lncRNAs), today … int j trad chin med